auditory verbal hallucinations (transdiagnostically)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) aged 14 to 25 years; 2) experiencing current and persisting AVH defined as a score of 1 (“voices occur at least once a week”) or above on the frequency item (no. 1) of the Psychotic Symptom Rating Scales-Auditory Hallucinations subscale (PSYRATS-AH); 3) experiencing distress due to voices, defined as a score of 2 (“a minority of voices is distressing (< 50%)” / “voices are moderately distressing”) or above on either of the distress items - amount of distress (no. 8) or intensity of distress (no. 9) - of the PSYRATS-AH; 4) written informed consent
Exclusion criteria
Exclusion criteria: 1) insufficient conduct of German; 2) AVH with an organic cause (e.g., brain disease or injury); 3) acute risk of harm to self or others that requires immediate crisis intervention; 4) inability to give informed consent and/or adhere with the study procedure; 5) currently receiving psychological treatment that specifically addresses hearing voices (e.g., cognitive behavioral therapy for voices); 6) intellectual disability
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Distress dimension of the Psychotic Symptom Rating Scales Auditory Hallucinations subscale (PSYRATS-AH) assessed after the intervention phase (T1) | — |
Secondary
| Measure | Time frame |
|---|---|
| voice-related distress (Distress subscale of the PSYHRATS-AH) at the 6-month follow-up (T2) perceived hostile intent and power of voices (Persecutory Beliefs subscales of the Revised Beliefs About Voices Questionnaire; BAVQ-R) after the intervention phase (T1) and at the 6-month follow-up (T2) perceived voice dominance (Voice and You-Revised; VAY-R) after the intervention phase (T1) and at the 6-month follow-up (T2) passive, aggressive, and assertive relating to voices (Assertive Responding to Voices, AppRoVE – Voices) after the intervention phase (T1) and at the 6-month follow-up (T2) negative core beliefs about the self (Brief Core Schema Scales, BCSS) after the intervention phase (T1) and at the 6-month follow-up (T2) | — |
Countries
Switzerland
Contacts
Universitätsklinik für Kinder- und Jugendpsychiatrie und Psychotherapie, Unversität Bern